Innovations in Retinal Vascular Diseases

Neuroinflammation in Focus in MS

Building on the Path in CRSwNP: Targeting Upstream Drivers With the Latest Biologic Approaches

APOE Status in Alzheimer’s Disease: Clinical Care in Europe

Smoothing the Way in EoE: Targeted, Team-Based Strategies for Pediatric and Adult Care

Neuroinflammation in Focus in MS

Next-Generation Anticoagulation Strategies for SSP and AF

Targeted Biologic Therapy for Optimal Patient Outcomes in CRSwNP

Sjögren’s Disease and the B-Cell Frontier

Preparing for the New Era of Blood-Based Biomarkers in Alzheimer’s Disease

Alzheimer’s Disease Case Conference: Visual Interpretation and Quantitative Analysis of Neuroimaging

Pulmonary Fibrosis: Fine-Tuning Diagnosis and Illuminating Novel Pathways for Emerging Treatments

ECHOing Innovation in COPD: Transforming Patient Care With the Use of Targeted Biologic Therapy

Frameworks for Identifying Systemic Sclerosis and Its Complications

Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin Based Therapies

RSV Prophylaxis Unveiled

APOE Status in Alzheimer s Disease Clinical Care in the United States

A Team Based Approach to Meningococcal Disease Vaccination for At Risk Populations

Shielding Generations WithPneumococcal Vaccination Approaches

Implementing Innovation in AD Approaches to New Diagnostics and Disease Modifying Therapies

The Latest Evidence in the Diagnosis & Management of Alzheimer's: Updates From CTAD 2025

Playing to Win in EoE – From Emergency Department Recognition to Continued Care Strategies

Beneath the Surface of Sjögren’s Disease

Remembering Brain Health: Modifiable Risk Factors and Early Detection of Cognitive Symptoms

Hypertrophic Cardiomyopathy Care in the CMI Era

Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines

Guiding Patients Through Cardio-Renal-Metabolic Conditions in Primary Care

Contemporary Insights on Diagnosing and Treating Transthyretin Cardiac Amyloidosis

Type 2 Inflammation in CRSwNP Optimizing Patient Identification & Targeted Treatment

Addressing Exacerbation in COPD: Strategies for Individualized Targeted Biologic Therapy

Toward Functional Cure in Chronic HBV

Building Clinical Confidence in the Diagnosis and Multidisciplinary Management of Rett Syndrome

Taking a New Look at PsA and Its Comorbidities Through the Lens of TYK2 Inhibition

Fibrosis, Flares, and Forward Thinking in IBD Care

Fibrosing ILDs: Pulmonologist Conversations on Timely Diagnosis and Antifibrotic Therapy

Exploring New Paradigms in Transthyretin Cardiac Amyloidosis Care

Quiet Progression, Loud Impact in MS

Advancing PBC Care Through Timely Referral and Treatment

Brain Health Morning Report Adapting Primary Care Practice and Workflows

Implementing Targeted Therapies in Transthyretin Cardiac Amyloidosis

Making Connections to Improve Patient Care in Obesity, Metabolism, and Liver Health

Improving the Care of Hereditary Angioedema: Maximizing Protection With Long-Term Prophylaxis

Tackling Obesity in Psoriatic Arthritis

Fine-Tuning Hypertrophic Cardiomyopathy Care in the CMI Era

Elevating Psoriasis and Comorbidity Management With TYK2 Inhibition

Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care

Accelerating Treatment Initiation and Supporting Patient Follow-Up in Pediatric EoE

Individualizing the PBC Care Pathway

From Screening Through Treatment: Proactive Engagement of Patients in Team-Based Care for PPD

Innovative Approaches to Manage Primary Biliary Cholangitis

The Path to Viral Hepatitis Elimination

Optimizing Obesity Management in Women Before, During, and After Pregnancy

Don’t Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel Agents

Transforming PBC Management: Targeted Relief and Improved Outcomes

Moving HCM Excellence Into the Fast Lane

Navigating Biologic Therapy in CRSwNP: From Patient Selection to Response Assessment

Mastering Cannabinoid Science: Key Insights for Informed Clinical Decision-Making

Achieving Goals in Lipid Management: Then and Now

Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond

Expert Perspectives on Novel Approaches to Therapy for ATTR Cardiac Amyloidosis